RT Journal Article
SR Electronic
T1 Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 6
OP 14
DO 10.2967/jnumed.120.253450
VO 62
IS 1
A1 Richard L. Wahl
A1 Panithaya Chareonthaitawee
A1 Bonnie Clarke
A1 Alexander Drzezga
A1 Liza Lindenberg
A1 Arman Rahmim
A1 James Thackeray
A1 Gary A. Ulaner
A1 Wolfgang Weber
A1 Katherine Zukotynski
A1 John Sunderland
YR 2021
UL http://jnm.snmjournals.org/content/62/1/6.abstract
AB The Society of Nuclear Medicine and Molecular Imaging created the Value Initiative in 2017 as a major component of its strategic plan to further demonstrate the value of molecular imaging and molecularly targeted radiopharmaceutical therapy to patients, physicians, payers, and funding agencies. The research and discovery domain, 1 of 5 under the Value Initiative, has a goal of advancing the research and development of diagnostic and therapeutic nuclear medicine. Research and discovery efforts and achievements are essential to ensure a bright future for NM and to translate science to practice. Given the remarkable progress in the field, leaders from the research and discovery domain and society councils identified 5 broad areas of opportunity with potential for substantive growth and clinical impact. This article discusses these 5 growth areas, identifying specific areas of particularly high importance for future study and development. As there was an understanding that goals should be both visionary yet achievable, this effort was called the Mars shot for nuclear medicine.